Schreiner MediPharm’s solution specifically developed for glass syringes consists of a plastic ring that is pushed on to the Luer adapter. The ring interlocks with the Luer adapter so that the different radii of the adapter and the syringe body are equalized. The plastic ring and the syringe body are subsequently connected with each other by means of a label to firmly fix the Luer adapter in place. This results in an extended label area offering ample space for additional product information.
Canada-based packaging and medication dispenser company Jones Healthcare Group is adding sustainable packaging products to its Qube and FlexRx medication adherence product lines for pharmacies.
The company has introduced the Qube Pro, FlexRx One and FlexRx Reseal blister packs made using Bio-PET, a medically approved bioplastic from plant-based material developer good natured.
These packs are intended to help pharmacies reduce their environmental footprints.
Jones Medication Adherence senior vice-president Trevor Noye said: “We continue to focus on circular design principles for our products to bring more sustainable packaging to the marketplace – it’s our responsibility, and it’s important to our pharmacy customers and the patients under their care.
“Not only is our new packaging the first to use leading-edge Bio-PET, but it also uses foil-free backings to improve recyclability.”
The Qube Pro, FlexRx One and FlexRx Reseal solutions are designed to increase the efficiency and quality of sealing in both automated and manual filling environments.
According to Jones Healthcare Group, the products take half as much time to seal as other comparable solutions on the market.
They will be made available to pharmacies in the first quarter of next year.
Consultation paper release by LawWiser urges Ministries and relevant stakeholders
to re-consider the Amendments to Plastics Waste Management Rules, 2016
Company’s groundbreaking mono-material barrier tube becomes first tube/cap combination successfully tested by EU-based cross-industry initiative, which promotes increased recycling and plastics circularity.
Oberdiessbach, Switzerland – Hoffmann Neopac, a global provider of high-quality packaging for pharma, beauty and oral care, has been granted RecyClass approval for its Polyfoil® MMB mono-material barrier tube, a groundbreaking combination of product protection, user friendliness and appealing aesthetics.
Becton, Dickinson, and Company (BD)’s BD SCF PremiumCoat Plunger Stopperade in partnership with Aptar Pharma, has been designed to support the injection of biologics into subcutaneous tissue with a -mL pre-filled syringe. BD and Aptar Pharma introduced the new stopper in October 2021.
The plunger stopper uses Aptar Pharma’s rubber formulation and film technology that is designed to limit drug component interactions and ensure drug integrity. According to an Oct. 13, 2021 BD press release, the product is designed to deliver improved functional performance, such as reduced glide force and glide force variability, in combination products. Quality of the stopper is verified in part through BD Viosioguard 100% camera inspection, which aims to ensure the product meets customer specifications and reduce the risk of foreign matter contamination.
“Biologics represent a critical and fast-growing segment of the drug market in the fight against serious diseases,” said Eric Borin, worldwide president of BD Medical-Pharmaceutical Systems, in the press release. “Enhanced biologic combination products are needed to ensure that patients and their caregivers can administer these drugs from the comfort of their homes. This partnership with Aptar Pharma will help deliver on that need.”
“The launch of BD SC PremiumCoat Plunger Stopper, merging BD and Aptar Pharma’s expertise, brings a new generation of coated plunger stopper solutions to the market to support the protection of sensitive drugs by reducing the quantity and species of probable leachables,” said Gabriel Zenker, president, Aptar Pharma Injectables, in the press release. “In partnering with BD, we look forward to furthering our support of biotech companies in their efforts to provide safe and easy-to-use drug delivery systems, while we continue to invest in new technologies to address the evolving needs of [the] market.”
The increasing demand for pharmaceutical packaging in emerging markets owing to better access to healthcare, rising healthcare expenses, and growing consumer awareness regarding healthier lifestyle. Also, advanced drug delivery and innovative packaging solutions with higher patient convenience and compliance drive the market for pharmaceutical packaging. Increasing occurrence of chronic diseases such as cancer, infectious diseases, and others and rising aging population necessitating advanced and patient friendly packaging are also expected to drive the market for pharmaceutical packaging during the forecast period.
Based on raw material, plastics is estimated to be the largest market in the overall pharmaceutical packaging market in 2021.
Plastics &polymers are widely used as raw materials for pharmaceutical packaging. Plastic provides freedom of design and cost-effective solution, making it a highly compatible solution for pharmaceutical packaging. The exceptional shatter resistance provided by plastics enables ease of handling and transportation. In addition, plastics can be attributed to their easy moldability, strength, and effective barrier against gas and vapor.
Based on type, plastic bottles is expected to be the largest pharmaceutical packaging segment in 2021.
Plastic bottles are suitable for storage of drugs in liquid and solid forms and can be coupled with the required type of cap & closure to suit specific applications such as nasal spray and ophthalmic drops. Growing use of oral drug delivery mode owing to patient compliance and convenience, increasing cases of communicable diseases, and rise in aging population in developed economies are responsible for the high share of the bottles segment.
Based on drug delivery, oral drug delivery is expected to be the largest pharmaceutical packaging segment in 2021.
Oral drug delivery mode is estimated to be the largest category in the overall pharmaceutical packaging market. This large market size can be attributed to the increased incidence of chronic diseases, improving patient compliance, convenient use, and reformulation and repositioning of drugs using advanced oral delivery systems, and heavy investments made by big pharmaceutical players for enhancing in-house capabilities to develop oral drug delivery technologies.
Based on region, APAC is projected to grow the fastest in the pharmaceutical packaging market during the forecast period.
APAC is projected to be the fastest-growing region amongst others in the pharmaceutical packaging market in 2020, in terms of value. Increasing government initiatives in emerging pharmaceutical market, increase in contract manufacturing activities, rise in aging population, and increased spending on healthcare are driving the market in APAC. China and India are the major markets in this region. In addition, growing technological advancements in healthcare sector in countries such as Singapore, China, Malaysia, Thailand, and others, increasing urbanization, and changing lifestyle are also some of the driving factors for the market growth in pharmaceutical packaging industry.
The key players in the pharmaceutical packaging market include Schott AG (Germany), Amcor (Switzerland), Aptar Group (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent (US), and WestRock (US). These players have established a strong foothold in the market by adopting strategies, such as new product launches, investment & expansions, agreements, partnerships, and mergers & acquisitions.
Berry Global is introducing its next generation of innovation with a range of packaging and product solutions, the Berry Global B Circular Range, that leverages the company’s engineering expertise and proprietary processes in the design for circularity to reduce products’ impact on the environment, focused on helping brand owners meet and exceed their sustainability goals.
• Event on November 9-11 offers chance for industry stakeholders to view Airnov’s range of sustainable healthcare packaging solutions.
• Airnov awarded EcoVadis certification after making series of sustainable operational and product improvements.
• Certification underlines Airnov’s commitment to make life better for healthcare patients while minimizing its impact on the environment.
– Airnov, a global leader in innovating packaging solutions for the healthcare market, will be showcasing its range of solutions at the CPhI Worldwide expo in Milan.
LupinLife’s Be One wins the best packaging design, graphics and brand value add award at the India Packaging Awards 2021News:
LupinLife, the consumer healthcare business of global pharma major Lupin Limited (Lupin), won the Best Packaging Design – Graphics and Brand Value Add Award at the India Packaging Awards for its daily health supplement – Be One. This award is an initiative by Informa Markets in India to honour the best branding initiatives from the pharma packaging space.
Be One is a scientifically tested supplement with the goodness of Ayurvedic marvel herbs – Ashwagandha, Pippali and Shatavari in a single vegetarian capsule. Daily consumption of this capsule helps in boosting vitality. In October 2021, Hrithik Roshan was named the Brand Ambassador for Be One.
Speaking on this association Anil Kaushal, Head of LupinLife Business, said, “We have received a phenomenal response to the launch of Be One and its design is as enthusing as its components. We are very humbled to receive this honour.”